Impact of the COVID-19 Pandemic and Lockdown on Gastric Bypass Results at 1-Year Follow-up.
Bariatric surgery
COVID-19
Coronavirus
Gastric bypass
Obesity
Weight loss
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
25
05
2021
accepted:
22
07
2021
revised:
22
07
2021
pubmed:
11
8
2021
medline:
28
9
2021
entrez:
10
8
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic caused a lockdown in many countries, which induced negative dietary habits and sedentary behavior. Studies suggest that weight loss of patients undergoing bariatric surgery was equally affected. The aim was to evaluate the impact of COVID-19 on weight loss, obesity-related comorbidities, and nutritional status at 1-year follow-up after gastric bypass (GB). Retrospective observational case-control study of patients undergoing primary GB in a tertiary referral Belgian center. COVID-19 period group was composed by those whose 1-year postoperative period was affected by the COVID-19 pandemic and lockdown: from October 1, 2019, to March 31, 2020. The control group was composed of patients operated from October 1, 2018, to March 31, 2019. Electronic clinical records were reviewed searching: baseline characteristics, weight and comorbidities evolution, and biochemical values. A total of 47 patients in the COVID-19 period group and 66 in the non-COVID-19 period group were analyzed. There were no significant differences in baseline characteristics. A reduced weight loss was observed at 1-year follow-up, in terms of percentage of excess weight loss (%EWL) (82.4% [SD: 21.6] vs. 82.4% [SD: 21.6]; p: 0.043) and body mass index (BMI) (27.8 kg/m The COVID-19 pandemic and lockdown had an impact on weight loss at 1-year follow-up after gastric bypass.
Identifiants
pubmed: 34374929
doi: 10.1007/s11695-021-05640-2
pii: 10.1007/s11695-021-05640-2
pmc: PMC8352749
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4511-4518Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
PLoS One. 2020 Apr 13;15(4):e0231229
pubmed: 32282816
Obes Surg. 2020 Jun;30(6):2071-2073
pubmed: 32291701
Nutr Clin Pract. 2015 Jun;30(3):371-82
pubmed: 25681484
Obes Surg. 2021 May;31(5):2115-2124
pubmed: 33486709
Int J Environ Res Public Health. 2020 Jun 10;17(11):
pubmed: 32532013
Nat Rev Endocrinol. 2012 Sep;8(9):544-56
pubmed: 22525731
Surg Obes Relat Dis. 2013 Mar-Apr;9(2):159-91
pubmed: 23537696
Surg Obes Relat Dis. 2021 Apr;17(4):756-764
pubmed: 33390351
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Obes Surg. 2020 Jan;30(1):169-173
pubmed: 31502183
Obes Surg. 2019 Feb;29(2):601-608
pubmed: 30411226
Surg Endosc. 2020 Jun;34(6):2332-2358
pubmed: 32328827
Front Nutr. 2021 Mar 04;8:626432
pubmed: 33748175
Int J Obes (Lond). 2007 Aug;31(8):1248-61
pubmed: 17356530
Obes Surg. 2021 Jun;31(6):2783
pubmed: 33515400
Obes Surg. 2021 Mar;31(3):942-948
pubmed: 33128218
Surg Obes Relat Dis. 2021 Jun;17(6):1165-1174
pubmed: 33812789
JAMA. 2018 Jan 16;319(3):255-265
pubmed: 29340679
Obes Surg. 2021 May;31(5):2197-2202
pubmed: 33527253
Obes Surg. 2021 Jul;31(7):3365-3368
pubmed: 33721193
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
Obes Surg. 2021 May;31(5):2330-2334
pubmed: 33231819
Cir Esp (Engl Ed). 2021 Jun-Jul;99(6):428-432
pubmed: 34130814
Surg Obes Relat Dis. 2021 Jan;17(1):208-214
pubmed: 33243670
JAMA. 2004 Oct 13;292(14):1724-37
pubmed: 15479938
Am J Med. 2009 Mar;122(3):248-256.e5
pubmed: 19272486
Appl Health Econ Health Policy. 2020 Aug;18(4):509-517
pubmed: 32495067
Appetite. 2021 Jul 1;162:105166
pubmed: 33610640
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Obes Surg. 2021 Jun;31(6):2614-2618
pubmed: 33608818